JANUMET

Type: Product
Name: JANUMET
First reported 17 hours ago - Updated 17 hours ago - 1 reports

Why Merck Is Heading To $65

Summary Management has not lost focus. Merck has a plan to attack and grow its share in immuno-oncologyand entering/dominating the hepatitis C (HCV) and vaccines market. Management continues to offset the near-term weakness with growth in diabetes, ... [Published Seeking Alpha - 17 hours ago]
First reported Jul 21 2014 - Updated Jul 22 2014 - 1 reports

5 More Possible Partners For MannKind's Afrezza, Each With A Strong Diabetes Care Franchise

Summary 5 Big Pharma companies not previously covered here have track records in the diabetes care niche that make them worthy of consideration as partners in marketing Afrezza. However, in all but one case, Afrezza may compete with their strongest ... [Published Seeking Alpha - Jul 21 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

Reducing prices of medicines but why only for diabetes and cardiac-care

Dear Editor,It refers to National Pharmaceutical Pricing Authority (NPPA) fixing lower prices for 108 drugs used for treating diabetic and cardio-vascular diseases keeping drug-manufacturers to mint money through an open loot by continuing them with liberty ... [Published Kashmir Times - Jul 18 2014]
First reported Jul 12 2014 - Updated Jul 12 2014 - 1 reports

Merck seeks to settle patent row with Glenmark

In the long-winding patent battle on a widely-prescribed diabetes drug, Januvia (sitagliptin), multinational company Merck (MSD) has sought a settlement to end the dispute with generic company, Glenmark on the blockbuster drug. Last year, US-based Merck's ... [Published Times of India - Jul 12 2014]
First reported Jul 11 2014 - Updated Jul 11 2014 - 1 reports

Is This MannKind's Greatest Risk?

Not long ago, some predicted that MannKind (NASDAQ: MNKDWith this regulatory hurdle out of the way, MannKind looks to be in the best position in the company's storied history. Nevertheless, some risks remain. Not if but whenThe most prominent risk that ... [Published Motley Fool - Jul 11 2014]
First reported Jul 09 2014 - Updated Jul 09 2014 - 1 reports

Insulin for Type 2

Doctors are starting people with Type 2 diabetes on insulin sooner, sometimes at diagnosis. But two recent studies give reason to question this treatment. If you have Type 2, is insulin right for you?The reason for starting insulin early is simple: Insulin ... [Published Diabetes Self-Management - Jul 09 2014]
First reported Jun 28 2014 - Updated Jun 28 2014 - 1 reports

FDA Approves Inhaled Insulin Drug Afrezza

FDA Approves Inhaled Insulin WebMD Health News By Valarie Basheda Reviewed by Brunilda Nazario, MD More from WebMD Taste Buds Decline With Age -- Link to Diabetes? Januvia, Janumet to... ... [Published KGet - Jun 28 2014]
First reported Jun 25 2014 - Updated Jun 25 2014 - 1 reports

Taste Buds Decline With Age -- Link to Diabetes?

Taste Buds Decline With Age -- Link With Diabetes? Medscape Medical News By Lisa Nainggolan Reviewed by Arefa Cassoobhoy, MD, MPH More from WebMD Januvia, Janumet to Note Pancreatitis Cases... ... [Published KGet - Jun 25 2014]
First reported Apr 30 2014 - Updated Apr 30 2014 - 1 reports

Merck & Co net earnings moves up by 7% in Q1

Merck & Co has reported net profit growth of 7 per cent during the first quarter ended March 2014 to $1,705 million from $1,593 million in the corresponding period of last year due to lower R&D expenditure and other costs. Its net sales, however, declined ... [Published PharmaBiz - Apr 30 2014]
First reported Apr 08 2014 - Updated Apr 08 2014 - 1 reports

Why Big Pharma May Not Be Cashing in on Medical Marijuana

Source: Thinkstock Prohibition against marijuana seems to be soon nearing an end, partially motivated by Colorado’s tax windfall since its passage of Amendment 64 , reporting over $3.5 million in revenue for February from recreational and medical ... [Published Wall St. Cheat Sheet - Apr 08 2014]
First reported Feb 27 2014 - Updated Feb 27 2014 - 1 reports

Januvia Pancreatic Cancer Allegations Help: Resource4thePeople...

National network of lawyers continues offer of complimentary consultations to consumers seeking compensation in lawsuits alleging links between diabetes medications Januvia, Byetta, Janumet and Victoza and pancreatic cancer. http://www.resource4thepe ... [Published PRWeb - Feb 27 2014]

Quotes

...Examples of such deals include the Merck's granting of ` "voluntary licence' to Emcure Pharma to manufacture and sell a low-cost version of HIV drug, raltegravir, and a recent agreement with Cipla on the same drug."
...the plaintiffs and defendants update the judge on the progress of the litigation and any problems that have developed," said Resource4thePeople. "We will monitor these developments and continue to update consumers who are following this litigation or are considering seeking compensation in connection with these allegations." The latest figures*** provided by the U S Judicial Panel for Multidistrict Litigation shows that there are now 163 cases in the multidistrict litigation...
...29, 2013, and the defendants must file their master consolidated answer no later than Dec. 31, 2013. "This order was issued after the latest status conference on Nov. 21, 2013, at which the judge was briefed on the progress of the case by attorneys for both sides,” said Resource4thePeople. “The filing of a master complaint will define the allegations in this litigation and the response will provide an answer to the charges from the defendants."
Rudolph Migliore, stated, "While modern medicine has done much to improve the quality of our lives, when defective products or prescription drugs cause unintended consequences, patients suffer unnecessarily from serious injuries." If you or someone you care about was diagnosed with pancreatic cancer after taking the prescription drug Januvia, Janumet, Byetta or Victoza, it is important...

More Content

All (29) | News (27) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Why Merck Is Heading To $65 [Published Seeking Alpha - 17 hours ago]
5 More Possible Partners For MannKind's Afrezza... [Published Seeking Alpha - Jul 21 2014]
Reducing prices of medicines but why only for d... [Published Kashmir Times - Jul 18 2014]
Merck seeks to settle patent row with Glenmark [Published Times of India - Jul 12 2014]
Is This MannKind's Greatest Risk? [Published Motley Fool - Jul 11 2014]
Insulin for Type 2 [Published Diabetes Self-Management - Jul 09 2014]
FDA Approves Inhaled Insulin Drug Afrezza [Published KGet - Jun 28 2014]
Taste Buds Decline With Age -- Link to Diabetes? [Published KGet - Jun 25 2014]
Merck & Co net earnings moves up by 7% in Q1 [Published PharmaBiz - Apr 30 2014]
Why Big Pharma May Not Be Cashing in on Medical... [Published Wall St. Cheat Sheet - Apr 08 2014]
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Mar 27 2014]
Januvia Pancreatic Cancer Allegations Help: Res... [Published PRWeb - Feb 27 2014]
Januvia Pancreatic Cancer Allegations Alert: Re... [Published PRWeb - Jan 19 2014]
TrialNetworks Welcomes Global Pharmaceutical In... [Published PRWeb - Jan 16 2014]
Byetta Pancreatic Cancer Allegations Attorneys:... [Published PRWeb - Dec 19 2013]
Byetta Pancreatic Cancer Allegation Attorneys: ... [Published PRWeb - Nov 27 2013]
DrugRisk November Januvia Update Shows Growth i... [Published PRWeb - Nov 27 2013]
DrugNews Adds Latest Court Update on Januvia La... [Published BioPortfolio - Nov 19 2013]
DrugRisk Adds Latest Court Information For Janu... [Published PRWeb - Nov 13 2013]
DrugNews Adds Byetta Resource Center With Lates... [Published PRWeb - Nov 08 2013]
DrugNews Adds Latest Januvia Warnings And Lawsu... [Published PRWeb - Nov 05 2013]
New York Attorney Now Accepting Januvia, Janume... [Published PRWeb - Nov 05 2013]
Byetta Pancreatic Cancer Allegations Lawyers: R... [Published PRWeb - Nov 05 2013]
DrugNews: Latest Court Records Show Growth of B... [Published PRWeb - Oct 26 2013]
DrugRisk Alerts of Court Update Showing Monthly... [Published PRWeb - Oct 24 2013]
DrugNews: Januvia Lawsuits Alleging Cancer Grow... [Published PRWeb - Oct 24 2013]
DrugRisk Announces Latest on Lawsuits Alleging ... [Published PRWeb - Oct 15 2013]
Latest Januvia Lawsuits Alleging Pancreatic Can... [Published PRWeb - Oct 14 2013]
Delhi High Court not to grant interim relief to... [Published Topnews.in - Apr 05 2013]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Why Big Pharma May Not Be Cashing in on Medical... [Published Wall St. Cheat Sheet - Apr 08 2014]
Source: Thinkstock Prohibition against marijuana seems to be soon nearing an end, partially motivated by Colorado’s tax windfall since its passage of Amendment 64 , reporting over $3.5 million in revenue for February from recreational and medical ...
Human medicines European public assessment repo... [Published Pending EC decisions and European Public Assess ... - Mar 27 2014]
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.